We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

22 hedge funds and large institutions have $30.6M invested in Tenax Therapeutics in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more call options, than puts

Call options by funds: $112K | Put options by funds: $86K

20% more capital invested

Capital invested by funds: $25.4M → $30.6M (+$5.13M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less funds holding

Funds holding: 23 → 22 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
22
Holders Change
-1
Holders Change %
-4.35%
% of All Funds
0.59%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
1
Increased
–
Reduced
4
Closed
2
Calls
$112K
Puts
$86K
Net Calls
+$26K
Net Calls Change
-$9K

Top Buyers

Rank Fund Capital Flow
1
EAM
EverPoint Asset Management
Connecticut
+$417K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$501K
2
SC
Scotia Capital
Ontario, Canada
-$218K
3
AC
Armistice Capital
New York
-$167K
4
OM
Opaleye Management
Massachusetts
-$83.4K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$83.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$6.67M -$501K -6 -7%
RCM
2
RA Capital Management
Massachusetts
$6.12M – – –
BC
3
Broadfin Capital
New York
$5.04M – – –
AC
4
Armistice Capital
New York
$2.84M -$167K -2 -5%
GPP
5
Great Point Partners
Connecticut
$2.84M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$2.49M -$83.4K -1 -3%
OM
7
Opaleye Management
Massachusetts
$1.19M -$83.4K -1 -6%
BBA
8
Baker Bros. Advisors
New York
$1.07M – – –
EAM
9
EverPoint Asset Management
Connecticut
$384K +$417K +5 New
Bank of New York Mellon
10
Bank of New York Mellon
New York
$332K – – –
Deutsche Bank
11
Deutsche Bank
Germany
$237K – – –
Geode Capital Management
12
Geode Capital Management
Massachusetts
$232K – – –
DCM
13
DAFNA Capital Management
California
$204K – – –
BCM
14
Bourgeon Capital Management
Connecticut
$168K – – –
BFA
15
BlackRock Fund Advisors
California
$156K – – –
NFA
16
Nationwide Fund Advisors
Ohio
$154K – – –
Dimensional Fund Advisors
17
Dimensional Fund Advisors
Texas
$103K – – –
Verition Fund Management
18
Verition Fund Management
Connecticut
$82K – – –
BIT
19
BlackRock Institutional Trust
California
$81K – – –
Northern Trust
20
Northern Trust
Illinois
$78K – – –
CS
21
Credit Suisse
Switzerland
$57K – – –
BIM
22
BlackRock Investment Management
Delaware
$11K – – –
UBS Group
23
UBS Group
Switzerland
$9K – – –
Morgan Stanley
24
Morgan Stanley
New York
$6K – – –
BA
25
BlackRock Advisors
Delaware
$5K – – –
1
2

TENX Hedge Fund Activity: Q2 2016 in Review

22 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q2 2016, worth a combined $30.6M — up 20% from $25.4M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of TENX and 1 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 0 added.

The largest buyer was EverPoint Asset Management, opening a new position worth an estimated $417K. The largest seller was Sabby Management, cutting an estimated $501K.

  • 22 institutional investors held Tenax Therapeutics (TENX) as of Q2 2016, down from 23 in Q1 2016.
  • Funds reported $30.6M of Tenax Therapeutics stock for Q2 2016, up 20% quarter-over-quarter.
  • 1 fund opened new Tenax Therapeutics positions in Q2 2016 and 2 closed out, a net change of -1 holder.
  • The largest Tenax Therapeutics buyer in Q2 2016 was EverPoint Asset Management, an estimated $417K added.
  • The largest Tenax Therapeutics seller in Q2 2016 was Sabby Management, an estimated $501K sold.

Based on aggregated 13F filings for Q2 2016.